Description
Afinitor (Everolimus) 5mg Online
Afinitor (Everolimus) is a kinase inhibitor, prescribed for kidney cancer, pancreatic cancer, brain tumor(astrocytoma), hormone-receptor-positive breast cancer in postmenopausal women, and prevents organ rejection in kidney therapy.
It prevents the growth of cancer cells.
Afinitor Everolimus is used to treat advanced renal cell carcinoma (RCC; cancer that begins in the kidneys) that has already been treated unsuccessfully with other medications. Afinitor is also used to treat a certain type of advanced breast cancer that has already been treated with at least one other medication. Afinitor is also used to treat a certain type of cancer of the pancreas, stomach, intestines, or lungs that has spread or progressed and that cannot be treated with surgery. Afinitor is also used to treat kidney tumors in people with tuberous sclerosis complex (TSC; a genetic condition that causes tumors to grow in many organs). Afinitor and Disperz are also used to treat subependymal giant cell astrocytoma (SEGA; a type of brain tumor) in adults and children 1 year of age and older who have TSC.
Afinitor is also used along with other medications to treat certain types of seizures in adults and children 2 years of age and older who have TSC. Afinitor is used with other medications to prevent transplant rejection (attack of the transplanted organ by the immune system of the person who received the organ) in certain adults who have received kidney transplants. Afinitor is a class of medications called kinase inhibitors. Afinitor treats cancer by stopping cancer cells from reproducing and by decreasing blood supply to the cancer cells. Afinitor prevents transplant rejection by decreasing the activity of the immune system.
